Refractory Childhood Epilepsy
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Refractory Childhood Epilepsy trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Refractory Childhood Epilepsy trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The purpose of the study is to evaluate the efficacy of perampanel as measured by the 50 percent (%) responder rate during the maintenance period of the core st…
This is an open-label observational study of pure CBD for the treatment for 25 children with intractable epilepsy. As pure CBD is not FDA approved, the investig…